AACR Supports Appointment of John E. Niederhuber as Director of the National Cancer Institute
August 18, 2006
Field(s) of Research
: Carcinogenesis, Cellular and Molecular Biology, Chemistry, Clinical Research, Endocrinology, Epidemiology, Experimental and Molecular Therapeutics, Immunology, Prevention Research, Tumor Biology
PHILADELPHIA – The American Association for Cancer Research (AACR), the world’s oldest and largest cancer research organization, congratulates Dr. John E. Niederhuber on his appointment as Director of the National Cancer Institute.
Dr. Niederhuber is a nationally recognized surgical oncologist with special clinical emphasis on gastrointestinal, hepatobiliary, and breast cancer. His pioneering work in hepatic artery infusion chemotherapy and implantable vascular access devices were major contributions to cancer care. He brings a long career of medical and administrative expertise to this position. Having served as a surgeon, laboratory and clinical researcher, cancer center director, and leader of several national cancer organizations, as well as in key senior positions at the National Cancer Institute, he has a unique perspective of the complexities of the cancer field from which to approach this new challenge. His experience will be vitally important in our efforts to further reduce cancer incidence and mortality.
“The AACR looks forward to working with Dr. Niederhuber to overcome the many challenges posed by this disease and to capitalize on the promise that three decades of investment have made available,” said Geoffrey Wahl, Ph.D., President of the American Association for Cancer Research.
Cancer research is advancing at a breathtaking pace. At this critical juncture in the evolution of cancer research, our ability to advance our understanding of the fundamental science of cancer, to make inroads in cancer prevention, and to speed the delivery of safe and effective therapies to patients has been severely constrained by inadequate funding. As a consequence, the NCI faces great challenges in meeting our mutual goal of further declines in cancer incidence, morbidity and mortality. “As Dr. Niederhuber stewards the NCI’s future investments in cancer research, the AACR will look to him for strong and creative leadership of the National Cancer Program to maintain the pace of current research while providing adequate and consistent funding to guarantee a place in cancer research for the bright young minds that will produce tomorrow’s discoveries,” said Dr. Wahl.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 24,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 60 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts over 16,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.
Staci Vernick Goldberg
215-440-9300 ext. 145